A PHASE III B, RANDOMIZED, TRIAL OF OPEN-LABEL EFAVIRENZ OR ATAZANAVIR WITH RITO

$47,250M01FY2008RRNIH

Indiana University Indianapolis, Indianapolis IN

Investigators

Mitchell J Goldmancontact

Linked publications, trials & patents

Paper 38712131 Paper 38198070 Paper 36172803 Paper 35776183 Paper 35728925 Paper 34238839 Paper 34096894 Paper 33478957 Paper 32507469 Paper 32446491 Paper 32111975 Paper 31985702 Paper 31735074 Paper 31691959 Paper 31427096 Paper 31356678 Paper 31190621 Paper 30991381 Paper 30855313 Paper 30747308 Paper 30737489 Paper 30631138 Paper 30504071 Paper 30217807 Paper 29872859 Paper 28724990 Paper 28647272 Paper 28643023 Paper 28451964 Paper 28369419 Paper 28325061 Paper 28283553 Paper 28199816 Paper 28003103 Paper 27943008 Paper 27799204 Paper 27549341 Paper 27533307 Paper 27455401 Paper 27432871 Paper 27423510 Paper 27074126 Paper 27009936 Paper 26965530 Paper 26923433 Paper 26914834 Paper 26852655 Paper 26732686 Paper 26536870 Paper 26262903 Paper 26080344 Paper 26009829 Paper 26002394 Paper 25990642 Paper 25734077 Paper 25714579 Paper 25352936 Paper 25117929 Paper 25064769 Paper 24945404 Paper 24904065 Paper 24819707 Paper 24802413 Paper 24747200 Paper 24711519 Paper 24637543 Paper 24393228 Paper 24384588 Paper 24378638 Paper 24370654 Paper 24309612 Paper 24121755 Paper 24084768 Paper 24067395 Paper 23908125 Trial NCT01223287 Trial NCT01223261 Trial NCT01203514 Trial NCT01203501 Trial NCT01203488 Trial NCT01203475 Trial NCT01203449 Trial NCT01203423 Trial NCT01035697 Trial NCT00874367 Trial NCT00233324 Trial NCT00114543 Trial NCT00109525 Trial NCT00067613 Trial NCT00063063 Trial NCT00016523 Trial NCT00011362 Trial NCT00009633 Trial NCT00009620 Trial NCT00005777 Trial NCT00005776 Trial NCT00005775 Trial NCT00005774 Trial NCT00005773 Trial NCT00005772

View original record on NIH RePORTER →